Microglia Involvement into Acute and Chronic Brain Damage in Diabetic Rats: Impact of GLP-1RA and SGLT-2i
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2907265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Anna Simanenkova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institution of Endocrinology, Almazov National Medical Research Centre, 197341 Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Experimental, Microglia, Glucagon-Like Peptide-1 Receptor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of Russian Federation.
Abstract (Originalsprache)
Background
Acute and chronic brain damage in type 2 diabetes mellitus (DM) determines the need to investigate the neuroprotective potential of glucose-lowering drugs. The purpose was to directly compare the neuroprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) with different duration of action and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in type 2 diabetic rats with and without stroke.
Methods
DM was modelled using high-fat diet and nicotinamide+streptozotocin protocol. The following groups (n = 15 each) were formed: DM without treatment, treatment with liraglutide, dulaglutide, canagliflozin as well as control group without DM and treatment. After 8 weeks, 10 rats from each group underwent middle cerebral artery occlusion. In the reperfusion period neurological deficit, neuroglial damage markers and brain necrosis were evaluated. Brain slices from the remaining 5 animals in each group were histologically examined for microglial activation and neuronal damage.
Results
Brain damage was similar in “DM” and “Control” (17.53 [14.23; 26.58] and 15.87 [13.40; 22.68] % of total brain volume, respectively). All study drugs diminished damage volume comparing with “DM” and “Control” whereas the necrosis volume in “DM+Liraglutide” was smaller than in “DM+Canagliflozin” and did not significantly differ from “DM+Dulaglutide” (2.9 [1.83; 4.71], 6.17 [3.88; 8.88] and 4.57 [3.27; 7.90] %). The neurological deficit was more prominent in “DM” than in “Control”, while all the drugs demonstrated similar positive effect. Neurofilament light chains (NLC) did not differ between “DM” and “Control”. Dulaglutide and canagliflozin caused a marked decrease in NLC. Protein S100BB level was similar in “DM” and “Control”. Liraglutide caused the largest S100BB decrease, while canagliflozin did not influence it. In chronic brain ischaemia, all drugs increased the number of normal neurons, but GLP-1RAs had a more pronounced effect. DM was accompanied by increased number of activated microglial cells in Cornu Ammonis (CA)1 hippocampal region. Both GLP-1RAs reduced the number of Iba-1-positive cells, with dulaglutide being more effective than liraglutide, whereas canagliflozin did not affect this parameter.
Conclusions
GLP-1RAs and SGLT-2i have neuroprotective properties against acute and chronic brain damage in diabetic rats, although the infarct-limiting effect of GLP-1RAs may be more pronounced. GLP-1RAs and SGLT-2i exert their protective effects by directly influencing neuronal survival, whereas GLP-1RAs also affect microglia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institution of Endocrinology, Almazov National Medical Research Centre, 197341 Saint-Petersburg, Russia.
- Faculty Therapy Department, Pavlov First St. Petersburg State Medical University, 197022 Saint-Petersburg, Russia.
- Laboratory of Functional Morphology of Central and Peripheral Nervous System, Institute of Experimental Medicine, 197022 Saint-Petersburg, Russia.
- Faculty of Pathophysiology, Pavlov First St. Petersburg State Medical University, 197022 Saint-Petersburg, Russia.
Förderung
- Ministry of Health of Russian Federation
Zitieren
APA
Simanenkova, A., Fuks, O., Timkina, N., Islamova, A., Sufieva, D., Kirik, О., Korzhevskii, D., Vlasov, T., & Karonova, T. (2024). Microglia Involvement into Acute and Chronic Brain Damage in Diabetic Rats: Impact of GLP-1RA and SGLT-2i. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907265
Vancouver
Simanenkova A, Fuks O, Timkina N, Islamova A, Sufieva D, Kirik О, et al. Microglia Involvement into Acute and Chronic Brain Damage in Diabetic Rats: Impact of GLP-1RA and SGLT-2i. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907265
BibTeX
@article{Simanenkova2024,
author = {Simanenkova, Anna and Fuks, Oksana and Timkina, Natalya and Islamova, Alina and Sufieva, Dina and Kirik, Оlga and Korzhevskii, Dmitrii and Vlasov, Timur and Karonova, Tatiana},
title = {Microglia Involvement into Acute and Chronic Brain Damage in Diabetic Rats: Impact of GLP-1RA and SGLT-2i},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2907265}
}
EUVIMED